Azenta (BA3) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BA3 Analyst Ratings

Moderate Buy

1 Buy

1 Hold

0 Sell

Based on 2 analysts giving stock ratings to

Azenta

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BA3 Stock 12 Month Forecast

Average Price Target

€23.02

▼(-5.67% Downside)

Based on 2 Wall Street analysts offering 12 month price targets for Azenta in the last 3 months. The average price target is €23.02 with a high forecast of €28.66 and a low forecast of €17.37. The average price target represents a -5.67% change from the last price of €24.40.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"€16","33":"€33","20.25":"€20.3","24.5":"€24.5","28.75":"€28.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28.66344954,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€28.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.01761857,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€23.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.371787599999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€17.37</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,20.25,24.5,28.75,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.4,24.727957656923074,25.055915313846153,25.38387297076923,25.711830627692308,26.039788284615383,26.36774594153846,26.695703598461538,27.023661255384614,27.351618912307693,27.67957656923077,28.007534226153844,28.335491883076923,{"y":28.66344954,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.4,24.293662966923076,24.187325933846154,24.08098890076923,23.974651867692305,23.868314834615383,23.76197780153846,23.655640768461538,23.549303735384616,23.442966702307693,23.336629669230767,23.230292636153845,23.123955603076922,{"y":23.01761857,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.4,23.859368276923075,23.31873655384615,22.77810483076923,22.237473107692306,21.696841384615382,21.15620966153846,20.615577938461534,20.074946215384614,19.53431449230769,18.993682769230766,18.453051046153846,17.912419323076918,{"y":17.371787599999998,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.2,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.6,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.2,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.2,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.5,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€28.66

Average Price Target€23.02

Lowest Price Target€17.37

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Saxon

Needham

€28.66

Buy

17.47%

Upside

Reiterated

08/04/26

Azenta: Buy Rating Reaffirmed as Strong Q3 Trends Support Outlook; $33 Price Target Maintained

Brendan Smith

TD Cowen

€26.06→€17.37

Hold

-28.80%

Downside

Reiterated

05/06/26

TD Cowen Keeps Their Hold Rating on Azenta (AZTA)

Vijay Kumar

Evercore ISI

€39.09→€30.4

Buy

24.59%

Upside

Assigned

04/06/26

Azenta price target lowered to $35 from $45 at Evercore ISIAzenta price target lowered to $35 from $45 at Evercore ISI

Matthew Stanton, CFA

Jefferies

€34.74→€30.4

Buy

24.59%

Upside

Reiterated

04/01/26

Azenta price target lowered to $35 from $40 at JefferiesAzenta price target lowered to $35 from $40 at Jefferies

Andrew Cooper

Raymond James

€30.4→€39.09

Buy

60.19%

Upside

Reiterated

11/25/25

Azenta price target raised to $45 from $35 at Raymond JamesAzenta price target raised to $45 from $35 at Raymond James

Thomas DeBourcy

Nephron

€26.93

Hold

10.35%

Upside

Upgraded

11/24/25

Azenta upgraded to Hold from Sell at Nephron ResearchAzenta upgraded to Hold from Sell at Nephron Research

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Saxon

Needham

€28.66

Buy

17.47%

Upside

Reiterated

08/04/26

Azenta: Buy Rating Reaffirmed as Strong Q3 Trends Support Outlook; $33 Price Target Maintained

Brendan Smith

TD Cowen

€26.06→€17.37

Hold

-28.80%

Downside

Reiterated

05/06/26

TD Cowen Keeps Their Hold Rating on Azenta (AZTA)

Vijay Kumar

Evercore ISI

€39.09→€30.4

Buy

24.59%

Upside

Assigned

04/06/26

Azenta price target lowered to $35 from $45 at Evercore ISIAzenta price target lowered to $35 from $45 at Evercore ISI

Matthew Stanton, CFA

Jefferies

€34.74→€30.4

Buy

24.59%

Upside

Reiterated

04/01/26

Azenta price target lowered to $35 from $40 at JefferiesAzenta price target lowered to $35 from $40 at Jefferies

Andrew Cooper

Raymond James

€30.4→€39.09

Buy

60.19%

Upside

Reiterated

11/25/25

Azenta price target raised to $45 from $35 at Raymond JamesAzenta price target raised to $45 from $35 at Raymond James

Thomas DeBourcy

Nephron

€26.93

Hold

10.35%

Upside

Upgraded

11/24/25

Azenta upgraded to Hold from Sell at Nephron ResearchAzenta upgraded to Hold from Sell at Nephron Research

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Azenta

3 Months

David SaxonNeedham

Success Rate

10/31 ratings generated profit

Average Return

-6.35%

Copying David Saxon's trades and holding each position for 3 Months would result in 32.26% of your transactions generating a profit, with an average return of -6.35% per trade.

1 Year

David SaxonNeedham

Success Rate

7/31 ratings generated profit

Average Return

-17.83%

Copying David Saxon's trades and holding each position for 1 Year would result in 22.58% of your transactions generating a profit, with an average return of -17.83% per trade.

2 Years

David SaxonNeedham

Success Rate

6/31 ratings generated profit

Average Return

-26.66%

Copying David Saxon's trades and holding each position for 2 Years would result in 19.35% of your transactions generating a profit, with an average return of -26.66% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BA3 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BA3 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BA3 average Analyst price target in the past 3 months is 23.02.

Each month's total comprises the sum of three months' worth of ratings.

BA3 Financial Forecast

BA3 Earnings Forecast

Next quarter’s earnings estimate for BA3 is €0.19 with a range of €0.16 to €0.22. The previous quarter’s EPS was €0.14. BA3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 40.24% of the time in the same period. In the last calendar year BA3 has Performed in-line its overall industry.

BA3 Sales Forecast

Next quarter’s sales forecast for BA3 is €137.09M with a range of €126.99M to €140.10M. The previous quarter’s sales results were €140.00M. BA3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 44.19% of the time in the same period. In the last calendar year BA3 has Performed in-line its overall industry.

BA3 Stock Forecast FAQ

What is DE:BA3’s average 12-month price target, according to analysts?

Based on analyst ratings, Azenta’s 12-month average price target is 23.02.

What is DE:BA3’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:BA3, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Azenta a Buy, Sell or Hold?

Azenta has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.

What is Azenta’s share price target?

The average share price target for Azenta is 23.02. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €28.66 ,and the lowest forecast is €17.37. The average share price target represents -5.67% Decrease from the current price of €24.4.

What do analysts say about Azenta?

Azenta’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of Azenta?

To buy shares of DE:BA3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Azenta (BA3) Stock Forecast & Price Target

BA3 Analyst Ratings

BA3 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Azenta

BA3 Analyst Recommendation Trends

BA3 Financial Forecast

BA3 Earnings Forecast

BA3 Sales Forecast

BA3 Stock Forecast FAQ

Detailed List of Analyst Forecasts